Antimicrobial susceptibility in Escherichia coli of human and avian origin—a comparison of wild-type distributions M. Sjölund, S. Bengtsson, J. Bonnedahl,

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs.

Antimicrobial susceptibility testing of colistin – evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli,

Distribution of phylogenetic groups, sequence type ST131, and virulence-associated traits among Escherichia coli isolates from men with pyelonephritis.

G. Cornaglia, A. Lönnroth, M. Struelens

D. Khalil, M. Hultin, M.U. Rashid, B. Lund

A new method for normalized interpretation of antimicrobial resistance from disk test results for comparative purposes G. Kronvall, G. Kahlmeter, E.

Varicella vaccination: a laboured take-off

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

P. Clarke, S. Murchan, E.G. Smyth, H. Humphreys

In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin- resistant Acinetobacter baumannii X. Vila-Farres, C. Garcia.

Migrant health—a cause for concern?

A.K. Reddy, P. Garg, I. Kaur Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Use of antimicrobials and resistance in bacteria isolated from blood cultures in a Danish county from 1992 to 1995 Thomas Lund S⊘rensen, Niels Frimodt-M⊘ller,

A new method for normalized interpretation of antimicrobial resistance from disk test results for comparative purposes G. Kronvall, G. Kahlmeter, E.

Gentamicin susceptibility in Escherichia coli related to the genetic background: problems with breakpoints L. Jakobsen, D. Sandvang, V.F. Jensen, A.M.

Quinolone resistance among Shigella spp

Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992–98 J. Robert, E. Cambau, K. Grenet, D.

Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program M.

Potential risk factors for infection with Candida spp

Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia.

C.G. Giske, C. Borén, B. Wretlind, G. Kronvall

Clinical Microbiology and Infection

W. Witte, B. Pasemann, C. Cuny Clinical Microbiology and Infection

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Cryptococcus neoformans var

Escherichia coli native valve endocarditis

D.E. Low Clinical Microbiology and Infection

Vector control: a cornerstone in the malaria elimination campaign

Sofie Arens, Jan Verhaegen, Ludo Verbist

Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs.

E.C. Böttger Clinical Microbiology and Infection

C. -J. Soussy, J. Nguyen, F. Goldstein, H. Dabernat, A. Andremont, R

Elements of design: the knowledge on which we build

S. Bengtsson, C. Bjelkenbrant, G. Kahlmeter

Microbiological and epidemiological studies of Enterococcus faecium resistant to amoxycillin in a university hospital in eastern France M. Thouverez,

Metagenomics and probiotics

J. Garau Clinical Microbiology and Infection

T.M. File Clinical Microbiology and Infection

Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases L. Romero, L. López,

Update on antifungal resistance in Aspergillus and Candida

Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union S. Bronzwaer Clinical.

Distribution of phylogenetic groups, sequence type ST131, and virulence-associated traits among Escherichia coli isolates from men with pyelonephritis.

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Comparative antimicrobial spectrum and activity of the desfluoroquinolone BMS (T-3811) tested against non-fermentative Gram-negative bacilli W.

P.M. Hawkey Clinical Microbiology and Infection

C. Oprica, C.E. Nord Clinical Microbiology and Infection

Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values J. Turnidge, G. Kahlmeter,

Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida

A sensitive and specific phenotypic assay for detection of metallo-β-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented.

C. Gagliotti, L. Nobilio, M.L. Moro

An after-hours clinical liaison blood culture service—is it worth it?

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Evaluation of the CLSI cefoxitin 30-µg disk-diffusion method for detecting methicillin resistance in staphylococci L.-X. Zhu, Z.-W. Zhang, C. Wang, H.-W.

Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting A. Kronenberg, S. Koenig, S. Droz,

Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories E. Matuschek,

Calibration of the disk diffusion test for trovafloxacin susceptibility testing of four anaerobic species G. Kronvall, E. Holst Clinical Microbiology.

Endotoxin release from Escherichia coli after exposure to tobramycin: dose-dependency and reduction in cefuroxime-induced endotoxin release J. SjöUlin,

Abstracts Clinical Microbiology and Infection

B.A. Cunha Clinical Microbiology and Infection

European recommendations for antimicrobial resistance surveillance

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

G. Kahlmeter Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

High prevalence of mutators among Enterobacter cloacae nosocomial isolates and their association with antimicrobial resistance and repetitive detection

The future of diagnostic bacteriology

Presentation transcript:

Antimicrobial susceptibility in Escherichia coli of human and avian origin—a comparison of wild-type distributions M. Sjölund, S. Bengtsson, J. Bonnedahl, J. Hernandez, B. Olsen, G. Kahlmeter Clinical Microbiology and Infection Volume 15, Issue 5, Pages 461-465 (May 2009) DOI: 10.1111/j.1469-0691.2009.02705.x Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Inhibition zone diameter histograms for clinical and avian isolates. The dashed line indicates the normalized resistance interpretation (NRI)-derived cut-off value for the wild-type population as determined by the NRI method. Clinical Microbiology and Infection 2009 15, 461-465DOI: (10.1111/j.1469-0691.2009.02705.x) Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 MIC histograms for clinical and avian isolates. The dashed line indicates the epidemiological cut-off values (ECOFFs) for the wild-type distribution as determined by EUCAST (http://www.eucast.org). aTrimethoprim concentration test range: 0.016–32 mg/L. Clinical Microbiology and Infection 2009 15, 461-465DOI: (10.1111/j.1469-0691.2009.02705.x) Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions